Lv4
530 积分 2024-09-09 加入
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
16天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
1个月前
已完结
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial
5个月前
已完结
人呼吸道合胞病毒感染监测与防控专家共识（2023年）
6个月前
已完结
Population pharmacokinetics and pharmacodynamics of eravacycline in patients with complicated intra-abdominal infections and community acquired bacterial pneumonia: support for a fixed-dose treatment regimen
8个月前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
10个月前
已完结
皖公网安备34019202002308
